Michael O'Connor, Ph.D., is a professor of radiologic physics at the Mayo Clinic in Rochester, Minn.


July 29, 2009 - Doctors at the Mayo Clinic in Rochester, Minn., have developed a "molecular imaging" technique for detecting cancer in dense breast tissue using radioactive tracers.
Presenting at the APPM 51st Annual Meeting in Anaheim, Calif., on July 28, 2009, Michael O'Connor, Ph.D., a professor of radiologic physics at Mayo, described the science behind this technique as well as the latest results from ongoing clinical trials, including one involving 1,000 women who all received the molecular imaging.

In the talk, "Molecular Imaging of the Breast," O'Connor explained how the technique has shown to be highly sensitive at detecting breast cancer. The key now is to make sure that the doses administered are as low as possible - equivalent to what you would receive in a mammogram. A study supported by the Susan G. Komen Foundation will begin enrolling 1,000 women in a few months to see how effective the technique is with low-dose formulations.

For more information: http://www.aapm.org/meetings/09AM/PRAbs.asp?mid=42&aid=11931


Related Content

News | Breast Imaging

March 30, 2026 — Each year, the Alumni Association at the University of Missouri-Kansas City, recognizes the ...

Time March 31, 2026
arrow
News | Radiology Imaging

March 26, 2026 — GE HealthCare has announced a renewed research collaboration with Stanford Medicine Department of ...

Time March 30, 2026
arrow
News | FDA

March 18, 2026 — FluoGuide A/S, a biotech company maximizing surgical outcomes in oncology, has announced that the U.S ...

Time March 24, 2026
arrow
News | MRI Breast | Breast cancer, dense breast, MRI

March 2, 2026 — A collaborative modeling study found that adding biennial breast magnetic resonance imaging (MRI) to ...

Time March 20, 2026
arrow
News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
News | PET-CT

Feb. 27, 2026 — A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little ...

Time February 26, 2026
arrow
News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
Subscribe Now